Trials / Completed
CompletedNCT03124693
Accuracy of Noninvasive Hemoglobin Measurement (SpHb) Using Rainbow DCI Pulse Oximeter Sensor
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 90 (actual)
- Sponsor
- Masimo Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
In this study, the concentration of hemoglobin within the subject's blood is affected by fluid status changes. The fluid status is affected by fluid loss during surgery for hospitalized study subjects or controlled administration of fluids intravenously for healthy study volunteers. The accuracy of a noninvasive hemoglobin sensor(s) will be assessed by comparing with blood sample analysis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Rainbow DCI pulse oximeter sensor |
Timeline
- Start date
- 2008-08-12
- Primary completion
- 2008-09-09
- Completion
- 2008-09-09
- First posted
- 2017-04-24
- Last updated
- 2017-06-12
- Results posted
- 2017-06-12
Locations
3 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03124693. Inclusion in this directory is not an endorsement.